Vactech is a startup based in Finland. Brouky records 2 investors associated with the company.
Vactech develops preventive vaccines and diagnostics targeting type 1 diabetes, celiac disease, and enterovirus-related conditions, focusing on innovative biotechnology solutions to reduce immune-mediated diseases globally.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.